Search Results

Sanofi Buys Provention Bio and its Type 1 Diabetes Drug for US$2.9 B.

• Authors : Haggerty, Lucy¹

Subjects: *TENDER offers; *MERGERS & acquisitions; *CONTRACTS

• Source: PharmaDeals Review. Mar2023, Vol. 2023 Issue 3, p13-13. 1p.

Record details

Theseus Pharmaceuticals, Inc. Files SEC Form SC TO-T/A, Tender Offer Statement By Third Party: (Jan. 30, 2024).

Subjects: TENDER offers; DRUGSUNITED States. Securities & Exchange Commission

• Source: Pharma Business Week; 2/13/2024, p1802-1802, 1p

Record details

Tenders Info Reports 08-31-2019: Philippines.

Subjects: *TENDER offers; *LETTING of contracts; MEDICAL suppliesPHILIPPINES

• Source: Tenders Info Reports. 8/31/2019, pN.PAG-N.PAG. 1p.

Record details

Tenders Info Reports 07-06-2019: Kazakhstan.

Subjects: *TENDER offers; *PUBLIC contracts; DRUGSKAZAKHSTAN

• Source: Tenders Info Reports. 7/6/2019, pN.PAG-N.PAG. 1p.

Record details

Tenders Info Reports 07-05-2019: Armenia.

Subjects: *TENDER offers; *LETTING of contracts; URBANIZATIONARMENIA

• Source: Tenders Info Reports. 7/5/2019, pN.PAG-N.PAG. 1p.

Record details

Intercept Pharmaceuticals, Inc. Files SEC Form SC14D9C, Written Communication Relating To Third Party Tender Offer: (Sept. 28, 2023).

Subjects: TENDER offers; DRUGS; BIOTECHNOLOGY industriesUNITED States. Securities & Exchange Commission

• Source: Pharma Business Week; 10/20/2023, p3804-3804, 1p

Record details

Intercept Pharmaceuticals, Inc. Files SEC Form SC14D9C, Written Communication Relating To Third Party Tender Offer: (Sept. 26, 2023).

Subjects: TENDER offers; DRUGS; BIOTECHNOLOGY industriesUNITED States. Securities & Exchange Commission

• Source: Pharma Business Week; 10/10/2023, p1840-1840, 1p

Record details

CSL Proposes $108m Merger with Zenyth.

Subjects: *TENDER offers; *MERGERS & acquisitions; DRUGSCSL Ltd. ; ZENYTH Therapeutics Ltd.

• Source: Asia Pacific Biotech News. 7/30/2006, Vol. 10 Issue 14, p736-737. 2p.

Record details

Ironwood Pharmaceuticals Inc. Files SEC Form SC TO-T/A, Tender Offer Statement By Third Party: (Jun. 16, 2023).

Subjects: TENDER offers; DRUGSUNITED States. Securities & Exchange Commission

• Source: Pharma Business Week; 7/3/2023, p1954-1954, 1p

Record details

Phathom Pharmaceuticals, Inc. Files SEC Form SC TO-I, Tender Offer Statement By Issuer: (Jun. 15, 2023).

Subjects: TENDER offers; DRUGSUNITED States. Securities & Exchange Commission

• Source: Pharma Business Week; 7/3/2023, p1998-1998, 1p

Record details